MedTrace Logo

Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task

NCT03837886 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-10-17

No results posted yet for this study

Summary

The aim of this study was to verify if sodium bicarbonate (NaHCO3) suplementation promotes changes in the performance, muscular activity and strength of individuals trained during the intermittent and intense task . Twelve trained adult men will participate in this randomized, double-blind, crossover clinical trial. Each participant should receive two types of intervention with a 14-day interval between conditions: alkalosis (ALK) in which gelatinous capsules containing 0.3 g.kg -1 of NaHCO 3 and placebo (PLA) are administered, in which 0.3 g.kg-1 of Calcium Carbonate (CaCO3). The following results will be considered: electromyographic activity (EMG) of the quadriceps muscle, peak torque, pH, lactate, and perception of effort, recovery and pain questionnaires, which will be collected during intermittent and high intensity DI protocol. ANOVA of repeated measures will be used to verify possible differences between groups.

Conditions

  • Sodium Bicarbonate
  • Alkalosis, Metabolic
  • Electromyography
  • Fatigue

Interventions

DIETARY_SUPPLEMENT

Sodium bicarbonate

The subjects should ingest 0.3g.kg of sodium bicarbonate 90 minutes before the beginning of the protocol task.

DIETARY_SUPPLEMENT

Calcium carbonate

The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of Calcium Carbonate

Sponsors & Collaborators

  • Marcelo Martins Kalytczak

    collaborator UNKNOWN

  • University of Nove de Julho

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
42 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-20
Primary Completion
2019-10-30
Completion
2019-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03837886 on ClinicalTrials.gov